Research Interest

Dr. Agostini's research program focuses on the study of genetic and molecular characterization of cancer, genetic pathways involved in the progression and outcome of colon cancer, and drug delivery system modulation.  In collaboration with researchers at The Methodist Hospital Research Institute (Houston, TX, USA), he is developing nanotechnology applications to enhance proteomic profiling for cancer research. His aims are to improve cancer detection by identifying specific cancer biomarkers and the timing of their interrelated functional molecular contributions to cancer progression.

Major Areas of Research

Cancer, molecular oncology, clinical nanotechnology applications, drug delivery system modulation

 

Marco Agostini

Research Scientist
Department of Oncology and Surgical Sciences 
University of Padova,  Padua, Italy
Phone: 0039-049-8214374 
E-mail:
 m.agostini@unipd.it